Biopharmaceutical Co. Raises $250M From RTW Investments
Biopharmaceutical company Cytokinetics said Tuesday it's entered a series of deals with funds backed by RTW Investments to raise $250 million and that have the potential to bring in an additional...To view the full article, register now.
Already a subscriber? Click here to view full article